QTTB - Q32 Bio Inc.
IEX Last Trade
43.04
3.800 8.829%
Share volume: 236,506
Last Updated: Fri 30 Aug 2024 09:59:21 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$39.24
3.80
9.68%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-15 | 2022-11-10 | 2023-03-09 | 2023-05-11 | 2023-08-14 | 2023-11-14 | 2024-03-13 | 2024-05-09 | |
| Assets | |||||||||
| Total Assets | 284.609 M | 262.651 M | 228.470 M | 197.881 M | 169.337 M | 140.063 M | 84.564 M | 152.334 M | |
| Current Assets | 238.440 M | 213.204 M | 181.015 M | 153.583 M | 131.336 M | 106.635 M | 83.914 M | 138.043 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 12.917 M | 12.130 M | 5.989 M | 3.558 M | 4.265 M | 3.023 M | 1.001 M | 2.731 M | |
| Short Term Investments | 12.917 M | 12.130 M | 5.989 M | 3.558 M | 4.265 M | 3.023 M | 1.001 M | 2.731 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 225.523 M | 201.074 M | 175.026 M | 150.025 M | 127.071 M | 103.298 M | 82.653 M | 135.312 M | |
| Total Non-current Assets | 46.169 M | 49.447 M | 47.455 M | 44.298 M | 38.001 M | 33.428 M | 650.000 K | 14.291 M | |
| Property Plant Equipment | 1.720 M | 1.415 M | 1.078 M | 1.062 M | 845.000 K | 0.000 | 0.000 | 1.659 M | |
| Other Assets | 15.151 M | 20.900 M | 20.563 M | 20.200 M | 19.837 M | 19.471 M | 650.000 K | 7.261 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 284.609 M | 262.651 M | 228.470 M | 197.881 M | 169.337 M | 140.063 M | 84.564 M | 152.334 M | |
| Total liabilities | 44.321 M | 53.590 M | 50.492 M | 45.982 M | 49.962 M | 51.852 M | 11.573 M | 103.565 M | |
| Total current liabilities | 20.734 M | 25.252 M | 22.576 M | 18.507 M | 22.939 M | 25.292 M | 11.573 M | 32.953 M | |
| Accounts Payable | 3.762 M | 4.835 M | 1.144 M | 3.635 M | 3.393 M | 7.803 M | 3.234 M | 4.960 M | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 55.113 M | |
| Current long term debt | 410.000 K | 1.489 M | 1.561 M | 1.626 M | 1.701 M | 1.778 M | 1.318 M | 3.088 M | |
| Long term debt | 23.587 M | 28.338 M | 27.916 M | 27.475 M | 27.023 M | 26.560 M | 0.000 | 15.499 M | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 55.113 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 240.288 M | 209.061 M | 177.978 M | 151.899 M | 119.375 M | 88.211 M | 72.991 M | 48.769 M | |
| Common stock | 3.188 M | 3.192 M | 3.194 M | 3.206 M | 3.211 M | 3.214 M | 3.221 M | 995.280 K | |
| Retained earnings | -361.116 M | -394.842 M | -429.137 M | -457.981 M | -493.025 M | -525.979 M | -542.098 M | -186.052 M |